Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Marcel Kool
Affiliation
Hopp Children's Cancer Center (KiTZ)
ORCID
Career Start Year
1990
Papers
329
H Index
90
Expertise
CM4AI Collaborator
Antoine Forget (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36356895
Rare embryonal and sarcomatous central nervous system tumours: State-of-the art and future directions.
Eur J Med Genet
2023
36356895
Rare embryonal and sarcomatous central nervous system tumours: State-of-the art and future directions.
Eur J Med Genet
2023
37679810
Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours.
Genome Med
2023
37835571
The Site of Origin of Medulloblastoma: Surgical Observations Correlated to Molecular Groups.
Cancers (Basel)
2023
37883081
Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial.
JAMA Oncol
2023
37093271
Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypes.
Acta Neuropathol
2023
36715306
Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroups.
Neuro Oncol
2023
37277823
Group-specific cellular metabolism in Medulloblastoma.
J Transl Med
2023
37085539
3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.
Nat Commun
2023
37020198
The potential of PARP as a therapeutic target across pediatric solid malignancies.
BMC Cancer
2023
37020038
Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities.
Oncogene
2023
36765089
Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability.
Nat Commun
2023
36702933
Comprehensive analysis of mutational signatures reveals distinct patterns and molecular processes across 27 pediatric cancers.
Nat Cancer
2023
36635768
Comparison of transcriptome profiles between medulloblastoma primary and recurrent tumors uncovers novel variance effects in relapses.
Acta Neuropathol Commun
2023
37450044
Recurrent atypical teratoid/rhabdoid tumors (AT/RT) reveal discrete features of progression on histology, epigenetics, copy number profiling, and transcriptomics.
Acta Neuropathol
2023
37441939
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Eur J Cancer
2023
37379234
Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.
Neuro Oncol
2023
37183219
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells.
J Neurooncol
2023
36459208
Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts.
Acta Neuropathol
2023
37501103
Mitochondrial DNA mutations in Medulloblastoma.
Acta Neuropathol Commun
2023
36782314
CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult population.
Acta Neuropathol Commun
2023
37835571
The Site of Origin of Medulloblastoma: Surgical Observations Correlated to Molecular Groups.
Cancers (Basel)
2023
37883081
Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial.
JAMA Oncol
2023
37501103
Mitochondrial DNA mutations in Medulloblastoma.
Acta Neuropathol Commun
2023
37679810
Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours.
Genome Med
2023
37085539
3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.
Nat Commun
2023
37020198
The potential of PARP as a therapeutic target across pediatric solid malignancies.
BMC Cancer
2023
37020038
Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities.
Oncogene
2023
37450044
Recurrent atypical teratoid/rhabdoid tumors (AT/RT) reveal discrete features of progression on histology, epigenetics, copy number profiling, and transcriptomics.
Acta Neuropathol
2023
37183219
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells.
J Neurooncol
2023
37379234
Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.
Neuro Oncol
2023
37277823
Group-specific cellular metabolism in Medulloblastoma.
J Transl Med
2023
37441939
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Eur J Cancer
2023
37093271
Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypes.
Acta Neuropathol
2023
36782314
CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult population.
Acta Neuropathol Commun
2023
36715306
Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroups.
Neuro Oncol
2023
36765089
Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability.
Nat Commun
2023
36635768
Comparison of transcriptome profiles between medulloblastoma primary and recurrent tumors uncovers novel variance effects in relapses.
Acta Neuropathol Commun
2023
36459208
Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts.
Acta Neuropathol
2023
36702933
Comprehensive analysis of mutational signatures reveals distinct patterns and molecular processes across 27 pediatric cancers.
Nat Cancer
2023
33283872
Corrigendum to: Molecular subgrouping of atypical teratoid/rhabdoid tumors-a reinvestigation and current consensus.
Neuro Oncol
2022
36182817
Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program 'iTHER'.
Eur J Cancer
2022
36180532
Multispectral confocal 3D imaging of intact healthy and tumor tissue using mLSR-3D.
Nat Protoc
2022
35771282
Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expression.
Acta Neuropathol
2022
35446794
SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors With Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation of Li-Fraumeni Syndrome.
Am J Surg Pathol
2022
36291912
Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a "MEMMAT-like" Metronomic Antiangiogenic Approach.
Cancers (Basel)
2022
35831316
The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors.
Nat Commun
2022
35501487
ATRT-SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significance.
Acta Neuropathol
2022
36137662
Imaging Characteristics of CNS Neuroblastoma-<i>FOXR2</i>: A Retrospective and Multi-Institutional Description of 25 Cases.
AJNR Am J Neuroradiol
2022
36127323
Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumors.
Cell Death Dis
2022
1 - 50 of 658
Column Actions
Search
Recommended Authors
Katherine E Miller
College of Medicine, The Ohio State University
Career Start Year
2017
Number of shared co-authors
7
Komal S Rathi
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year
2014
Number of shared co-authors
29
Jaime M Guidry Auvil
National Cancer Institute
Career Start Year
2013
Number of shared co-authors
30
Hiromichi Suzuki
Graduate School of Medicine, Kyoto University
Career Start Year
2012
Number of shared co-authors
91
Krutika S Gaonkar
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year
2012
Number of shared co-authors
27
David R Raleigh
University of California san francisco
Career Start Year
2010
Number of shared co-authors
32
Daniela S Gerhard
National Cancer Institute
Career Start Year
2009
Number of shared co-authors
29
Payal Jain
Maharaja Agrasen Medical College
Career Start Year
2009
Number of shared co-authors
30
Ludivine Coudi??re Morrison
University of Manitoba
Career Start Year
2007
Number of shared co-authors
66
Matthew D Wood
Oregon Health & Science University
Career Start Year
2007
Number of shared co-authors
38
Etienne Danis
University of Colorado Anschutz Medical Campus
Career Start Year
2004
Number of shared co-authors
5
Massimo Squatrito
Seve Ballesteros Foundation Brain Tumor group
Career Start Year
2002
Number of shared co-authors
15
Daniel Martinez
Perelman School of Medicine at the University of Pennsylvania
Career Start Year
2002
Number of shared co-authors
25
Jun S Wei
Center for Cancer Research, National Cancer Institute
Career Start Year
2001
Number of shared co-authors
25
Tamra E Werbowetski-Ogilvie
University of Manitoba
Career Start Year
2001
Number of shared co-authors
66
Eve Lapouble
Institut Curie
Career Start Year
2000
Number of shared co-authors
23
Xiang Chen
St. Jude Children's Research Hospital
Career Start Year
1999
Number of shared co-authors
39
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year
1997
Number of shared co-authors
5
Qing-Rong Chen
Center for Biomedical Informatics and Information Technology
Career Start Year
1996
Number of shared co-authors
7
Erik P Sulman
NYU Grossman School of Medicine
Career Start Year
1995
Number of shared co-authors
35
Kristina A Cole
Perelman School of Medicine, University of Pennsylvania
Career Start Year
1994
Number of shared co-authors
44
Javed Khan
Center for Cancer Research, National Cancer Institute
Career Start Year
1993
Number of shared co-authors
51
Joseph F Costello
University of California san francisco
Career Start Year
1991
Number of shared co-authors
53
Glenn S Cowley
Broad Institute of Harvard and MIT
Career Start Year
1990
Number of shared co-authors
14
E Alejandro Sweet-Cordero
University of California San Francisco
Career Start Year
1989
Number of shared co-authors
29
Antonio Iavarone
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Career Start Year
1989
Number of shared co-authors
48
Glenn M Marshall
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year
1989
Number of shared co-authors
22
James F Amatruda
Children's Hospital of Los Angeles
Career Start Year
1988
Number of shared co-authors
19
John M Maris
Children's Hospital of Philadelphia
Career Start Year
1985
Number of shared co-authors
83
Charles Keller
Children's Cancer Therapy Development Institute
Career Start Year
1980
Number of shared co-authors
15
row(s) 1 - 30 of 30
Collaborators
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
198
Andrey Korshunov
Institute of Pathology, University Hospital Heidelberg
Co-authored papers
133
David T W Jones
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
110
Michael D Taylor
The Hospital for Sick Children
Co-authored papers
72
Paul A Northcott
St Jude Children's Research Hospital
Co-authored papers
68
Andreas von Deimling
Co-authored papers
67
Peter Lichter
German Cancer Research Center (DKFZ)
Co-authored papers
61
Ulrich Sch??ller
University Medical Center Hamburg-Eppendorf
Co-authored papers
47
Marc Remke
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers
47
Marina Ryzhova
N.N. Burdenko Neurosurgical Institute
Co-authored papers
46
Stefan Rutkowski
University Medical Center Hamburg-Eppendorf
Co-authored papers
45
Till Milde
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
44
Pascal D Johann
Co-authored papers
42
Michael C Frühwald
Co-authored papers
40
Torsten Pietsch
Co-authored papers
40
Dominik Sturm
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
39
Felix Sahm
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
38
Nada Jabado
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers
38
Olaf Witt
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
38
Vijay Ramaswamy
Hospital for Sick Children
Co-authored papers
36
Kristian W Pajtler
Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University
Co-authored papers
36
David Capper
Charite University Medicine Berlin
Co-authored papers
33
Martin Sill
Co-authored papers
31
Hendrik Witt
Co-authored papers
31
Jan Koster
Amsterdam University Medical Centers location AMC
Co-authored papers
30
Katja von Hoff
Co-authored papers
29
David W Ellison
St. Jude Children's Research Hospital
Co-authored papers
28
Natalie J??ger
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
26
Christine Haberler
Co-authored papers
25
Lukas Chavez
University of California San Diego
Co-authored papers
25
1 - 30